WuXi Biologics increases issued shares in June 2025

WuXi Biologics (Cayman) Inc. announced a net increase of 221,536 in issued shares for the month of June 2025, bringing the total to 4,068,902,309. The increase stems from the exercise of share options under various Pre-IPO Share Option Schemes and restricted share award scheme, raising a total of USD59,423.86 during the month. While issued shares increased, the number of authorized shares remains unchanged at 6,000,000,000. The company clarified that no further share options could be granted under the Pre-IPO Share Option Scheme after the shares were listed. As of the end of June, total authorized share capital stood at USD50,000. The company's par value of the ordinary shares remains USD1/120,000.